Aemulus Holdings Bhd (0181) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aemulus Holdings Bhd (0181) has a cash flow conversion efficiency ratio of -0.202x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-22.92 Million ≈ $-5.76 Million USD) by net assets (RM113.42 Million ≈ $28.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Aemulus Holdings Bhd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Aemulus Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Aemulus Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aemulus Holdings Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aemulus Holdings Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chin Yang Ind
KO:003780
|
0.030x |
|
Eastwood Bio-Medical Canada Inc
V:EBM
|
0.001x |
|
Renishaw PLC
LSE:RSW
|
0.040x |
|
Creas F&C Co.Ltd
KQ:110790
|
-0.010x |
|
Claranova SE
PA:CLA
|
-1.143x |
|
Korea Computer Inc
KQ:054040
|
0.041x |
|
SOLUCIONES CUATROO.EO-04
F:5XW
|
N/A |
|
Golden House
TA:GOHO
|
0.019x |
Annual Cash Flow Conversion Efficiency for Aemulus Holdings Bhd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Aemulus Holdings Bhd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 0181 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | RM113.42 Million ≈ $28.48 Million |
RM-30.00 Million ≈ $-7.53 Million |
-0.264x | -164.05% |
| 2024-09-30 | RM113.17 Million ≈ $28.41 Million |
RM-11.34 Million ≈ $-2.85 Million |
-0.100x | +11.23% |
| 2023-09-30 | RM135.29 Million ≈ $33.97 Million |
RM-15.27 Million ≈ $-3.83 Million |
-0.113x | +35.91% |
| 2022-09-30 | RM189.01 Million ≈ $47.45 Million |
RM-33.28 Million ≈ $-8.36 Million |
-0.176x | -460.70% |
| 2021-09-30 | RM112.61 Million ≈ $28.27 Million |
RM-3.54 Million ≈ $-887.85K |
-0.031x | -390.81% |
| 2020-09-30 | RM101.70 Million ≈ $25.53 Million |
RM-650.65K ≈ $-163.36K |
-0.006x | +89.69% |
| 2019-09-30 | RM74.04 Million ≈ $18.59 Million |
RM-4.60 Million ≈ $-1.15 Million |
-0.062x | -353.81% |
| 2018-09-30 | RM78.50 Million ≈ $19.71 Million |
RM1.92 Million ≈ $481.94K |
0.024x | +146.75% |
| 2017-09-30 | RM73.09 Million ≈ $18.35 Million |
RM-3.82 Million ≈ $-959.72K |
-0.052x | +57.49% |
| 2016-09-30 | RM65.47 Million ≈ $16.44 Million |
RM-8.05 Million ≈ $-2.02 Million |
-0.123x | -203.75% |
| 2015-09-30 | RM68.21 Million ≈ $17.13 Million |
RM8.09 Million ≈ $2.03 Million |
0.119x | -- |
About Aemulus Holdings Bhd
Aemulus Holdings Berhad, an investment holding company, designs and develops automated test equipment, and test and measurement instruments in Malaysia, China, Singapore, Vietnam, Korea, the United States, Taiwan, and internationally. It offers include Amoeba 7600-SR, Amoeba5600, Amoeba 4200, and Amoeba 1831 equipment. The company also provides design consultancy and test-related services. In add… Read more